Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-11-069572
Filing Date
2011-03-17
Accepted
2011-03-17 10:18:01
Documents
3
Period of Report
2011-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d6k.htm 6-K 11105
2 PRESS RELEASE dex991.htm EX-99.1 21018
3 GRAPHIC g163379g11q47.jpg GRAPHIC 17423
  Complete submission text file 0001193125-11-069572.txt   57267
Mailing Address 200-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 200-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS CORP (Filer) CIK: 0001447028 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-34949 | Film No.: 11693918
SIC: 2834 Pharmaceutical Preparations